Zobrazeno 1 - 10
of 130
pro vyhledávání: '"G G, Steger"'
Autor:
M, Hejna, W J, Köstler, M, Raderer, G G, Steger, T, Brodowicz, W, Scheithauer, C, Wiltschke, C C, Zielinski
Publikováno v:
European journal of cancer (Oxford, England : 1990). 37(16)
We have conducted a prospective controlled randomised clinical study testing for the efficacy of topical GM-CSF (molgramostim), as compared to the combined topical use of an antiseptic agent (povidone-iodine) and amphotericin B (AA) in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2a91aa31f237327b43bbc2a421d61238
https://pubmed.ncbi.nlm.nih.gov/11597373
https://pubmed.ncbi.nlm.nih.gov/11597373
Autor:
M, Schmidinger, A C, Budinsky, C, Wenzel, M, Piribauer, R, Brix, M, Kautzky, W, Oder, G J, Locker, C C, Zielinski, G G, Steger
Publikováno v:
Wiener klinische Wochenschrift. 112(14)
Glutathione has been shown to be an effective chemoprotector against cisplatin-induced side effects in patients with ovarian cancer. In view of this fact, we performed a randomized clinical pilot-trial in the management of other solid tumors in order
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b2d12e82c07b84b17be70f360cf351dd
https://pubmed.ncbi.nlm.nih.gov/11008323
https://pubmed.ncbi.nlm.nih.gov/11008323
Autor:
M, Schmidinger, G G, Steger, C, Wenzel, G J, Locker, T, Brodowicz, A C, Budinsky, C, Wiltschke, G, Kramer, M, Marberger, C C, Zielinski
Publikováno v:
Cancer immunology, immunotherapy : CII. 49(7)
Because of the known efficacy of several cytokines in the treatment of advanced renal cell cancer (RCC), we have conducted a phase II trial of the efficacy and toxicity of subcutaneous interferon gamma (IFNgamma) and interleukin-2 (IL-2).63 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::292d8fdf5fbf725330502bd48ff512a6
https://pubmed.ncbi.nlm.nih.gov/10999466
https://pubmed.ncbi.nlm.nih.gov/10999466
Autor:
G J, Locker, S, Kapiotis, M, Veitl, R M, Mader, B, Stoiser, J, Kofler, A E, Sieder, H, Rainer, G G, Steger, C, Mannhalter, O F, Wagner
Publikováno v:
British journal of haematology. 105(4)
Treatment with intravenous recombinant human interleukin-2 (rh IL-2) is frequently accompanied by the capillary leak syndrome and disturbances of the coagulation system. Although the exact mechanisms are still not fully understood, the involvement of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b76962e7aaa74cacba6d8b4a9e88443d
https://pubmed.ncbi.nlm.nih.gov/10554800
https://pubmed.ncbi.nlm.nih.gov/10554800
Publikováno v:
International journal of cancer. 73(6)
Amplification and over-expression of the HER-2/neu proto-oncogene are associated with poor prognosis in women with both node-positive and node-negative breast cancer. Therefore, the encoded surface glycoprotein represents an attractive target for can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b18419deeb10c62c02146897d9dd1121
https://pubmed.ncbi.nlm.nih.gov/9399669
https://pubmed.ncbi.nlm.nih.gov/9399669
Autor:
H, Pirc-Danoewinata, A, Chott, E, Onderka, J, Drach, E, Schlögl, U, Jäger, F, Thalhammer, H, Nowotny, D, Aryee, G G, Steger
Publikováno v:
Leukemia. 8(11)
In malignant non-Hodgkin lymphomas (NHL), cytogenetic analysis may provide prognostic information including prediction of histologic evolution and responsiveness to therapy. In this study, we correlate clinical data and chromosomal aberrations in 70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7e09b00828885e3c12d4b367b95e3353
https://pubmed.ncbi.nlm.nih.gov/7967739
https://pubmed.ncbi.nlm.nih.gov/7967739
Autor:
G G, Steger, W C, Pierce, R, Figlin, J, Czernin, R, Kaboo, J B, DeKernion, T, Okarma, A, Belldegrun
Publikováno v:
Clinical immunology and immunopathology. 72(2)
Murine systems have demonstrated improved anti-tumor efficacy when tumor-infiltrating lymphocytes (TIL) are combined with interleukin-2 (IL-2). One goal of human adoptive immunotherapy is to identify and expand TIL with specific activity against auto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::01dbe0ae633beec3265d060dff25e602
https://pubmed.ncbi.nlm.nih.gov/8050198
https://pubmed.ncbi.nlm.nih.gov/8050198
Autor:
G G, Steger
Publikováno v:
Krankenpflege Journal. 30(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::57b7e34fc6b12ccc2a11d63c9299e0e4
https://pubmed.ncbi.nlm.nih.gov/1564898
https://pubmed.ncbi.nlm.nih.gov/1564898
Autor:
C. Wenzel, D. Hussian, R. Bartsch, U. Pluschnig, G. J. Locker, M. Gnant, R. Jakesz, C. C. Zielinski, G. G. Steger
Publikováno v:
Journal of Clinical Oncology. 22:714-714
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6043a5fe7e697a8947a702146c9b662
https://doi.org/10.1200/jco.2004.22.90140.714
https://doi.org/10.1200/jco.2004.22.90140.714
Autor:
G. G. Steger, E. Kubista, H. Hausmaninger, M. Gnant, C. Tausch, A. Lang, H. Samonigg, A. Galid, R. Jakesz
Publikováno v:
Journal of Clinical Oncology. 22:553-553
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74c357444e10309a74ccbc4c24a33793
https://doi.org/10.1200/jco.2004.22.90140.553
https://doi.org/10.1200/jco.2004.22.90140.553